IMMX insider buying
3 cluster buysImmix Biopharma, Inc. · Healthcare
When two or more insiders at Immix Biopharma, Inc. buy IMMX on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in IMMX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Sep 16 – Dec 10, 2025Detected Dec 10, 2025High conviction2 insidersTotal bought$20.2KMarket cap$743.9M
- Jun 18 – Jun 18, 2025Detected Jun 18, 2025High conviction2 insidersTotal bought$10.1KMarket cap$743.9M
- May 14 – Aug 22, 2024Detected Aug 22, 2024High conviction4 insidersTotal bought$132.3KMarket cap$743.9M
All notable open-market buys in IMMX
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Dec 10, 2025 | Morris Gabriel Scluster Director, CFO | 770 | $6.58 | $5.1K | SEC ↗ |
| Dec 10, 2025 | Rachman Ilya Mcluster Director, CEO and Chairman | 746 | $6.67 | $5.0K | SEC ↗ |
| Sep 17, 2025 | Rachman Ilya Mcluster Director, CEO and Chairman | 2,500 | $2.02 | $5.1K | SEC ↗ |
| Sep 16, 2025 | Morris Gabriel Scluster Director, CFO | 2,600 | $1.97 | $5.1K | SEC ↗ |
| Jun 18, 2025 | Morris Gabriel Scluster Director, CFO | 2,225 | $2.28 | $5.1K | SEC ↗ |
| Jun 18, 2025 | Rachman Ilya Mcluster Director, CEO and Chairman | 2,178 | $2.30 | $5.0K | SEC ↗ |
| Dec 23, 2024 | Director | 40,000 | $2.19 | $87.6K | SEC ↗ |
| Dec 20, 2024 | Director | 7,700 | $2.17 | $16.7K | SEC ↗ |
| Aug 22, 2024 | Hsu Jasoncluster Director | 8,100 | $2.25 | $18.2K | SEC ↗ |
| Aug 21, 2024 | Hsu Jasoncluster Director | 15,000 | $2.23 | $33.5K | SEC ↗ |
| Aug 16, 2024 | Ng Careycluster Director | 10,000 | $1.86 | $18.6K | SEC ↗ |
| Jul 24, 2024 | Hsu Jasoncluster Director | 6,000 | $2.15 | $12.9K | SEC ↗ |
| Jul 18, 2024 | Hsu Jasoncluster Director | 3,200 | $2.07 | $6.6K | SEC ↗ |
| Jun 7, 2024 | Rachman Ilya Mcluster Director, CEO and Chairman | 2,600 | $2.13 | $5.5K | SEC ↗ |
| Jun 7, 2024 | Morris Gabriel Scluster Director, CFO | 2,500 | $2.12 | $5.3K | SEC ↗ |
| Jun 4, 2024 | Morris Gabriel Scluster Director, CFO | 3,300 | $1.81 | $6.0K | SEC ↗ |
| Jun 4, 2024 | Rachman Ilya Mcluster Director, CEO and Chairman | 3,300 | $1.81 | $6.0K | SEC ↗ |
| May 14, 2024 | Morris Gabriel Scluster Director, CFO | 4,500 | $2.23 | $10.0K | SEC ↗ |
| May 14, 2024 | Rachman Ilya Mcluster Director, CEO and Chairman | 4,300 | $2.25 | $9.7K | SEC ↗ |
More Healthcare stocks with insider cluster buys
IMMX insider buying — FAQ
- Are insiders buying IMMX stock?
- Yes — 4 distinct insiders have bought IMMX (Immix Biopharma, Inc.) on the open market, including 3 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Dec 10, 2025.
- How much IMMX stock have insiders bought?
- Insiders have bought a combined $266.9K of IMMX across 19 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in IMMX?
- A cluster buy is two or more distinct Immix Biopharma, Inc. insiders — officers, directors, or 10% owners — each buying IMMX on the open market within a rolling window. IMMX has 3 detected cluster buys to date.
- Where does this IMMX insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in IMMX
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy IMMX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding IMMX.